Quick Answer
LifeStance Health Group, Inc. reported Net Income Loss of $9.66 million for the year ending 2025.
- LifeStance Health Group, Inc. showed an increase of +116.8% in Net Income Loss from 2024 to 2025.
- This data is from LifeStance Health Group, Inc.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2019 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2020: -$27.60 million | Q2 2020: -$24.95 million | Q2 2020: -$4.34 million | Q3 2020: -$3.29 million | Q1 2021: -$8.68 million | Q2 2021: -$70.03 million | Q3 2021: -$120.45 million | Q1 2022: -$62.33 million | Q2 2022: -$68.73 million | Q3 2022: -$37.85 million | Q1 2023: -$34.24 million | Q2 2023: -$45.48 million | Q3 2023: -$61.58 million | Q1 2024: -$21.10 million | Q2 2024: -$23.28 million | Q3 2024: -$5.96 million | Q1 2025: $709.0 thousand | Q2 2025: -$3.79 million | Q3 2025: $1.08 million.
- Over the full 6 years of available data (2019 to 2025), LifeStance Health Group, Inc.'s Net Income Loss has grown by 70.5%.
- Historical annual values: Fiscal year 2025: $9.66 million | Fiscal year 2024: -$57.44 million | Fiscal year 2023: -$186.26 million | Fiscal year 2022: -$215.56 million | Fiscal year 2021: -$307.20 million | Fiscal year 2019: $5.67 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: